Claudius Mahr

CSWG-SCAI Stages Combined With Machine Learning–Based Phenotypes for Serial Risk Stratification in Cardiogenic Shock

Impact of Comorbidity Burden on Outcome in Patients with Cardiogenic Shock: A Cardiogenic Shock Working Group analysis

Serial Shock Severity Assessment Within 72 Hours After Diagnosis

Seated Pulmonary Artery Pressure Monitoring in Patients With Heart Failure

Clinical outcomes among cardiogenic shock patients supported with high-capacity Impella axial flow pumps: A report from the Cardiogenic Shock Working Group

Factors associated with acute limb ischemia in cardiogenic shock and downstream clinical outcomes: Insights from the Cardiogenic Shock Working Group

Association of Hemometabolic Trajectory and Mortality: Insights From the Cardiogenic Shock Working Group Registry

Pulmonary Artery Catheter Use and Risk of In-hospital Death in Heart Failure Cardiogenic Shock

Clinical Course of Patients in Cardiogenic Shock Stratified by Phenotype

Impact of Female Sex on Cardiogenic Shock Outcomes

Outcomes of Patients Transferred to Tertiary Care Centers for Treatment of Cardiogenic Shock: A Cardiogenic Shock Working Group Analysis

Surfaceome mapping of primary human heart cells with CellSurfer uncovers cardiomyocyte surface protein LSMEM2 and proteome dynamics in failing hearts

Treatment Intensity for the Management of Cardiogenic Shock

Criteria for Defining Stages of Cardiogenic Shock Severity

Clinical Presentation and In-Hospital Trajectory of Heart Failure and Cardiogenic Shock

Rationale and Design of the Proactive-HF Trial for Managing Patients With NYHA Class III Heart Failure by Using the Combined Cordella Pulmonary Artery Sensor and the Cordella Heart Failure System

Effect of Treatment With Sacubitril/Valsartan in Patients With Advanced Heart Failure and Reduced Ejection Fraction

Right Ventricular Dysfunction Is Common and Identifies Patients at Risk of Dying in Cardiogenic Shock

Concordance of Treatment Effect: An Analysis of The Society of Thoracic Surgeons Intermacs Database

Complete Hemodynamic Profiling With Pulmonary Artery Catheters in Cardiogenic Shock Is Associated With Lower In-Hospital Mortality

Variant Interpretation for Dilated Cardiomyopathy

Sacubitril/Valsartan in Advanced Heart Failure With Reduced Ejection Fraction

Outcome Differences in Acute vs. Acute on Chronic Heart Failure and Cardiogenic Shock

Evaluation of a lateral thoracotomy implant approach for a centrifugal-flow left ventricular assist device: The LATERAL clinical trial

HVAD: The ENDURANCE Supplemental Trial

Blood damage in Left Ventricular Assist Devices: Pump thrombosis or system thrombosis?

Toward Genetics-Driven Early Intervention in Dilated Cardiomyopathy

Biventricular Support With Intracorporeal, Continuous Flow, Centrifugal Ventricular Assist Devices

The Treatment of Patients with Advanced Heart Failure Ineligible for Cardiac Transplantation with the HeartWare Ventricular Assist Device: Results of the ENDURANCE Supplement Trial